Immunologic Research

, Volume 9, Issue 3, pp 178–189 | Cite as

Interactions between immunogenic peptides and HLA-DR molecules

  • Jonathan B. Rothbard
  • Robert Busch
MHC Class II Genes and Molecules, Symposium (Part III)


Peptide Immunogenic Peptide Restriction Element Hybrid Peptide Critical Contact 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Honjo T: Immunoglobulin genes. Ann Rev Immunol 1983; 1: 499–528.CrossRefGoogle Scholar
  2. 2.
    Moller O: Role of somatic mutation in the generation of lymphocyte diversity. Immunol Rev 1987; 96: 1–162.Google Scholar
  3. 3.
    Davis M, Bjorkman P: T cell antigen receptor genes and T cell recognition. Nature 1988; 334: 395–400.PubMedCrossRefGoogle Scholar
  4. 4.
    Bjorkman P, Saper M, Samraoui B, et al: Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987; 329: 506–511.PubMedCrossRefGoogle Scholar
  5. 5.
    Bjorkman P, Saper M, Samraoui B, et al: The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987; 329: 512–517.PubMedCrossRefGoogle Scholar
  6. 6.
    Babbitt B, Allen P, Matsueda G, et al: The binding of immunogenic peptides to Ia histocompatibility molecules. Nature 1985; 317: 359–362.PubMedCrossRefGoogle Scholar
  7. 7.
    Buus S, Sette A, Colon S, et al: Isolation and characterisation of antigen-IA complexes in T cell recognition. Cell 1986; 47: 1071–1076.PubMedCrossRefGoogle Scholar
  8. 8.
    Buus S, Sette A, Colon S, et al: The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science 1987; 235: 1353–1357.PubMedCrossRefGoogle Scholar
  9. 9.
    Watts T, McConnell H: High affinity fluorescent peptide binding to I-Ad in lipid membranes. Proc Natl Acad Sci USA 1986; 83: 9660–9664.PubMedCrossRefGoogle Scholar
  10. 10.
    Busch R, Howland K, Fenton C, et al: Binding of peptides to MHC class II proteins on B cell surfaces. Manuscript submitted.Google Scholar
  11. 11.
    Ceppellini R, Frumento G, Ferrara G, et al.: Binding of labeled influenza matrix peptide 17–29 to HLA-DR in living B lymphoid cells. Manuscript submitted.Google Scholar
  12. 12.
    Sadegh-Nasseri S, McConnell H: A kinetic intermediate in the reaction of an antigenic peptide and I-Ek. Nature 1989; 337: 274–275.PubMedCrossRefGoogle Scholar
  13. 13.
    Buus S, Sette A, Colon S, et al: Autologous peptides constitutively occupy the antigen binding site on Ia. Science 1988; 242: 1045–1046.PubMedCrossRefGoogle Scholar
  14. 14.
    Rothbard J, Taylor W: A sequence pattern common to T cell epitopes. EMBO J 1988; 7: 93–98.PubMedGoogle Scholar
  15. 15.
    DeLisi C, Berzofsky J: T cell antigenic sites tend to be amphipathic structures. Proc Natl Acad Sci USA 1985; 82: 7048–7052.PubMedCrossRefGoogle Scholar
  16. 16.
    Rothbard J, Lechler R, Howland K, et al: Structural model of HLA-DR1 restricted T cell antigen recognition. Cell 1988; 52: 515–523.PubMedCrossRefGoogle Scholar
  17. 17.
    Rothbard J, Pemberton R, Bodmer H, et al: Identification of residues necessary for clonally specific recognition of a cytotoxic T cell determinant. EMBO J 1989; 8: 2321–2328.PubMedGoogle Scholar
  18. 18.
    Allen P, Matsueda G, Evans R, et al: Identification of the T cell and Ia contact residues of a T cell antigenic epitope. Nature 1987; 327: 713–716.PubMedCrossRefGoogle Scholar
  19. 19.
    Sette A, Buus S, Colon S, et al: Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells. Nature 1987; 28: 395–399.CrossRefGoogle Scholar
  20. 20.
    Hofmann K, Titus G, Montibeller J, et al: Avidin binding of carboxyl substituted biotin and analogues. Biochemistry 1982; 21: 978–982.PubMedCrossRefGoogle Scholar
  21. 21.
    Accolla R: Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets. J Exp Med 1983; 157: 1053–1060.PubMedCrossRefGoogle Scholar
  22. 22.
    Hume C, Accolla R, Lee J: Defective HLA class II expression in a regulatory mutant is partially complemented by activated ras oncogenes. Proc Natl Acad Sci USA 1987; 84: 8603–8607.PubMedCrossRefGoogle Scholar
  23. 23.
    Lechler R, Bal V, Rothbard J, et al: HLA-DR restricted antigen induced activation of human helper T lymphocyte clone using transfected murine cell lines. J Immunol 1988; 141: 3003–3007.PubMedGoogle Scholar
  24. 24.
    Shackelford D, Lampson L, Strominger J: Separation of three class II antigens from a homozygous human B cell line. J Immunol 1983; 130: 289–294.PubMedGoogle Scholar
  25. 25.
    Guillet J, Lai M, Briner T, et al: Immunological self, non-self. Science 1987; 235: 865–870.PubMedCrossRefGoogle Scholar
  26. 26.
    DeKretser T, et al: Eur J Immunol 1982; 12: 214–221.CrossRefGoogle Scholar

Copyright information

© S. Karger AG 1990

Authors and Affiliations

  • Jonathan B. Rothbard
    • 1
  • Robert Busch
    • 1
  1. 1.ImmuLogic Pharmaceutical Corp.Palo Alto(USA)

Personalised recommendations